R. Huang, J. Chen, B. Guo, C. Jiang, W. Sun, Diabetes-induced male infertility: potential mechanisms and treatment options. Mol Med 30, 11 (2024). https://doi.org/10.1186/s10020-023-00771-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Y. Cao, Z. Jin, Y. Xi, J. Cheng, Z. Fang, Q. Zhao et al., Roles of ferroptosis in type 1 diabetes induced spermatogenic dysfunction. Free Radic. Biol. Med 214, 193–205 (2024). https://doi.org/10.1016/j.freeradbiomed.2024.02.006.

Article  CAS  PubMed  Google Scholar 

M.L. Eisenberg, S.C. Esteves, D.J. Lamb, J.M. Hotaling, A. Giwercman, K. Hwang et al., Male infertility. Nat Rev. Dis. Prim. 9, 49 (2023). https://doi.org/10.1038/s41572-023-00459-w.

Article  PubMed  Google Scholar 

D.F. Carrageta, B. Guerra-Carvalho, M.A. Spadella, M. Yeste, P.F. Oliveira, M.G. Alves, Animal models of male reproductive ageing to study testosterone production and spermatogenesis. Rev Endocr. Metab. Disord. 23, 1341–1360 (2022). https://doi.org/10.1007/s11154-022-09726-9.

Article  CAS  PubMed  Google Scholar 

B. Kreymann, G. Williams, M.A. Ghatei, S.R. Bloom, Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 2, 1300–1304 (1987). https://doi.org/10.1016/s0140-6736(87)91194-9.

Article  CAS  PubMed  Google Scholar 

H. Yao, A. Zhang, D. Li, Y. Wu, C.Z. Wang, J.Y. Wan et al., Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis. Bmj 384, e076410 (2024). https://doi.org/10.1136/bmj-2023-076410.

Article  CAS  PubMed  PubMed Central  Google Scholar 

P. Pavli, O. Triantafyllidou, E. Kapantais, N.F. Vlahos, G. Valsamakis, Infertility improvement after medical weight loss in women and men: a review of the literature. Int J. Mol. Sci. 25, 1909 (2024). https://doi.org/10.3390/ijms25031909.

Article  CAS  PubMed  PubMed Central  Google Scholar 

C. Able, B. Liao, G. Saffati, A. Maremanda, J. Applewhite, A.A. Nasrallah et al. Prescribing semaglutide for weight loss in non-diabetic, obese patients is associated with an increased risk of erectile dysfunction: a TriNetX database study. Int J Impot Res. Published online. (2024). https://doi.org/10.1038/s41443-024-00895-6

X. Cui, J. Feng, T. Wei, L. Gu, D. Wang, S. Lang et al., Pro-α-cell-derived β-cells contribute to β-cell neogenesis induced by antagonistic glucagon receptor antibody in type 2 diabetic mice. iScience 25, 104567 (2022). https://doi.org/10.1016/j.isci.2022.104567.

Article  CAS  PubMed  PubMed Central  Google Scholar 

M.M. Holter, D.J. Phuong, I. Lee, M. Saikia, L. Weikert, S. Fountain et al., 14-3-3-zeta mediates GLP-1 receptor agonist action to alter α cell proglucagon processing. Sci Adv. 8, eabn3773 (2022). https://doi.org/10.1126/sciadv.abn3773.

Article  CAS  PubMed  PubMed Central  Google Scholar 

J. Liu, K. Yang, J. Yang, W. Xiao, Y. Le, F. Yu et al., Liver-derived fibroblast growth factor 21 mediates effects of glucagon-like peptide-1 in attenuating hepatic glucose output. EBioMedicine 41, 73–84 (2019). https://doi.org/10.1016/j.ebiom.2019.02.037.

Article  PubMed  PubMed Central  Google Scholar 

M.H. Noyan-Ashraf, M.A. Momen, K. Ban, A.M. Sadi, Y.Q. Zhou, A.M. Riazi et al., GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice. Diabetes 58, 975–983 (2009). https://doi.org/10.2337/db08-1193.

Article  CAS  PubMed  PubMed Central  Google Scholar 

H. Fujita, T. Morii, H. Fujishima, T. Sato, T. Shimizu, M. Hosoba et al., The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential. Kidney Int 85, 579–589 (2014). https://doi.org/10.1038/ki.2013.427.

Article  CAS  PubMed  Google Scholar 

O.L. Blanchard, J.M. Smoliga, Translating dosages from animal models to human clinical trials–revisiting body surface area scaling. Faseb j. 29, 1629–1634 (2015). https://doi.org/10.1096/fj.14-269043.

Article  CAS  PubMed  Google Scholar 

J.K. Mader, L. Jensen, S.H. Ingwersen, E. Christiansen, S. Heller, T.R. Pieber, Pharmacokinetic properties of liraglutide as adjunct to insulin in subjects with type 1 diabetes mellitus. Clin Pharmacokinet. 55, 1457–1463 (2016). https://doi.org/10.1007/s40262-016-0413-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

T. Wei, X. Cui, Y. Jiang, K. Wang, D. Wang, F. Li et al., Glucagon acting at the GLP-1 receptor contributes to β-cell regeneration induced by glucagon receptor antagonism in diabetic mice. Diabetes 72, 599–610 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Y. Jiang, J. Yang, L. Xia, T. Wei, X. Cui, D. Wang et al., Gut microbiota-tryptophan metabolism-GLP-1 axis participates in β-cell regeneration induced by dapagliflozin. Diabetes 73, 926–940 (2024). https://doi.org/10.2337/db23-0553.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Z. Jin, Y. Yang, Y. Cao, Q. Wen, Y. Xi, J. Cheng et al., The gut metabolite 3-hydroxyphenylacetic acid rejuvenates spermatogenic dysfunction in aged mice through GPX4-mediated ferroptosis. Microbiome 11, 212 (2023). https://doi.org/10.1186/s40168-023-01659-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Z.C. Luo, Z.R. Jin, Y.F. Jiang, T.J. Wei, Y.L. Cao, Z. Zhang et al., The protective effects and underlying mechanisms of dapagliflozin on diabetes-induced testicular dysfunction. Asian J. Androl. 25, 331–338 (2023). https://doi.org/10.4103/aja202242.

Article  CAS  PubMed  Google Scholar 

M.E. Dasso, C.L. Centola, M.N. Galardo, S.B. Meroni, M.F. Riera, Glucagon-like peptide-1 analog, liraglutide, regulates Sertoli cell energy metabolism. J Endocrinol. 263, e240274 (2024). https://doi.org/10.1530/joe-24-0274.

Article  CAS  PubMed  Google Scholar 

X.D. Yang, Y.Y. Yang, Clinical pharmacokinetics of semaglutide: a systematic review. Drug Des. Devel Ther. 18, 2555–2570 (2024). https://doi.org/10.2147/dddt.S470826.

Article  PubMed  PubMed Central  Google Scholar 

E. Watson, D.M. Jonker, L.V. Jacobsen, S.H. Ingwersen, Population pharmacokinetics of liraglutide, a once-daily human glucagon-like peptide-1 analog, in healthy volunteers and subjects with type 2 diabetes, and comparison to twice-daily exenatide. J Clin. Pharm. 50, 886–894 (2010). https://doi.org/10.1177/0091270009354996.

Article  CAS  Google Scholar 

F. Meng, X. Li, J. Li, Y. Zhu, M. Su, B. Zhang et al., Fluornen-9-bisphenol increases Leydig cell proliferation but inhibits maturation in pubertal male rats via interacting with androgen receptor as an antagonist and estrogen receptor α as an agonist. Chem Biol. Interact. 363, 110024 (2022). https://doi.org/10.1016/j.cbi.2022.110024.

Article  CAS  PubMed  Google Scholar 

World Health Orgnization. WHO laboratory manual for the examination and processing of human semen. Availalble from: https://www.who.int. [Last accessed 27 July 2021].

F. Li, W. Si, L. Xia, D. Yin, T. Wei, M. Tao et al., Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma. Mol Cancer 23, 90 (2024). https://doi.org/10.1186/s12943-024-02008-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

K. Wang, X. Cui, F. Li, L. Xia, T. Wei, J. Liu et al., Glucagon receptor blockage inhibits β-cell dedifferentiation through FoxO1. Am J. Physiol. Endocrinol. Metab. 324, E97–E113 (2023). https://doi.org/10.1152/ajpendo.00101.2022.

Article  CAS  PubMed  Google Scholar 

C. Wu, X. Jin, G. Tsueng, C. Afrasiabi, A.I. Su, BioGPS: building your own mash-up of gene annotations and expression profiles. Nucleic Acids Res 44, D313–D316 (2016). https://doi.org/10.1093/nar/gkv1104.

Article  CAS  PubMed  Google Scholar 

E. Sjöstedt, W. Zhong, L. Fagerberg, M. Karlsson, N. Mitsios, C. Adori et al., An atlas of the protein-coding genes in the human, pig, and mouse brain. Science 367, eaay5947 (2020). https://doi.org/10.1126/science.aay5947.